Robot model
Butterfly iQ+
The Butterfly iQ+ is a handheld, single-probe whole-body ultrasound system that uses patented Ultrasound-on-Chip semiconductor technology.
- Manufacturer
- Butterfly Network
- Form factor
- biometric
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 2
- Website
- butterflynetwork.com ↗
The verified answer
As of Aug 2026, DEPLOY verifies Butterfly iQ+, a biometric by Butterfly Network (commercial): 2 verified deployments on record. 1 source back the record.
Butterfly iQ+ holds 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 1 filingsOverview
The Butterfly iQ+ is a handheld, single-probe whole-body ultrasound system that uses patented Ultrasound-on-Chip semiconductor technology. It connects to a smartphone and is FDA-cleared for 13 clinical applications including cardiac, abdominal, lung, vascular, and obstetric imaging.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Price
Type
Data & sources
Web sources
1
1 source backing this record.View all →
Availability and pricing
- Availability
- Not disclosed
- Price
- $3K (actual sale price)as of 2025-01-01
- Units in field
- Not disclosed
- Sales model
- Not disclosed
- Lead time
- Not disclosed
Pricing
One-time purchase
$2,699 - $0 USDactual sale priceas of 2025-01-01
Price status: actual-sale-price = real published price at time of sale; manufacturer-target = vendor target, not yet realized; analyst-estimate = third-party projection, not a vendor figure; not-announced = no price on record.
Prices verified as of Jan 1, 2025
Deployments (2)
- Butterfly iQ+ at South Africaoperational
Butterfly partnered with CHAI and GUSI to deploy probes for maternal and fetal health in South Africa, funded by the Gates Foundation grant.
- Butterfly iQ+ at Kenyaoperational
500 Butterfly iQ+ devices deployed to healthcare workers across Kenya as part of a 5M USD Gates Foundation grant for maternal and fetal health in Sub-Saharan Africa.
Butterfly iQ+ on the deployment map
View the global mapWhere Butterfly iQ+ is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 3, 2026
Added to the verified registry
- Price point recorded: $2,699VerifiedJan 1, 2025
Actual sale price
- Deployment verifiedVerifiedJan 1, 2023
at South Africa
- Deployment verifiedVerifiedMar 9, 2022
at Kenya
Regulatory filings (1)
- K232808fda 510k · us_fdacleared2023-01-01
Applicant: Butterfly Network
Safety record
No incidents on record for Butterfly iQ+.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
What is Butterfly iQ+?
How much does Butterfly iQ+ cost?
Is Butterfly iQ+ actually deployed in the real world?
Who makes Butterfly iQ+?
Where is Butterfly iQ+ deployed?
Can you buy Butterfly iQ+?
Is Butterfly iQ+ FDA cleared?
What are alternatives to Butterfly iQ+?
How does Butterfly iQ+ compare to Blackrock Neuroport Array?
Is Butterfly iQ+ a top biometric?
What is Butterfly iQ+'s maturity stage?
Is Butterfly iQ+ safe?
How does the Butterfly iQ+ compare to other handheld ultrasounds?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-08
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-08
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: biometric
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Butterfly iQ+.Recent coverage
Butterfly iQ+ in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Butterfly iQ+ from third-party publications. Automatically surfaced; not part of the verified registry record.
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool
Butterfly received FDA clearance for a fully automated Gestational Age Tool integrated into its handheld ultrasound, a milestone for women's health.
Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool
FDA cleared Butterfly Network's AI ultrasound tool for fetal biometric measurements. 21M+ images. Under 2 minutes.
Butterfly Network Reports Fourth Quarter 2025 Financial Results
Butterfly reported record Q4 revenue of 31.5M USD with 41 percent YoY growth and positive net cash flow.
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool
Butterfly Network received FDA clearance for its blind sweep ultrasound AI tool for pregnancy, delivering fetal biometric estimates in under two minutes without requiring users to…
Butterfly Network Reports Fourth Quarter 2024 Financial Results
Butterfly Network reported Q4 2024 total revenue of $22.4 million, up 35% year-over-year, with US revenue of $14.5 million.
Butterfly Announces FDA Clearance of its Next-Gen Handheld Ultrasound Butterfly iQ3
Butterfly Network received FDA clearance for the Butterfly iQ3, its next-generation handheld ultrasound with improved image quality and new digital imaging modes.
Butterfly Network Names Joseph M. DeVivo as President and Chief Executive Officer
Butterfly appointed health tech executive Joseph DeVivo as CEO and Chairman, bringing over 35 years of medtech leadership experience.
Butterfly Network Distributes 500 Butterfly iQ+ Devices to Healthcare Workers in Kenya
Butterfly deployed 500 iQ+ devices to healthcare workers in Kenya as part of a 5M USD Gates Foundation grant to expand medical imaging access in Sub-Saharan Africa.
Mintz Represents Butterfly Network in 1.5B USD SPAC Deal
Butterfly Network merged with Longview Acquisition Corp in a SPAC deal valuing the company at approximately 1.5B USD ahead of its NYSE listing.
Atrium Health and Butterfly Network Drive Innovation in Medical Imaging During COVID-19 Battle
Atrium Health deployed a large fleet of Butterfly iQ devices used to perform thousands of scans during the COVID-19 pandemic.
Machine-readable surfaces
- Markdown mirror: /models/butterfly-iq-plus.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/aed64d0b-bb26-4f48-8a32-1a6a7187fdbd
- Revision history: /models/butterfly-iq-plus/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Butterfly iQ+ draws attention at the 42nd percentile but verifies reality at the 69th percentile among biometric robots. Hype Gap -27.4, 14th widest among biometric robots.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 17, 2026